Nanotechnology as a New Therapeutic Approach to Prevent the HIV-Infection of Treg Cells

• Didiana Jaramillo-Ruiz,

  Affiliation Laboratorio InmunoBiología Molecular, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Spanish HIV HGM BioBank, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain

  ⨯
• Francisco Javier De La Mata,

  Affiliation Departamento de Química Inorgánica and Química Orgánica, Universidad de Alcalá, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain

  ⨯
• Rafael Gómez,

  Affiliation Departamento de Química Inorgánica and Química Orgánica, Universidad de Alcalá, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain

  ⨯
• Rafael Correa-Rocha,

  Affiliation Laboratorio InmunoBiología Molecular, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Spanish HIV HGM BioBank, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain

  ⨯
• Mª Ángeles Muñoz-Fernández

  * E-mail: mmunoz.hgugm@gmail.com or mmunoz.hgugm@salud.madrid.org

  Affiliation Laboratorio InmunoBiología Molecular, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Spanish HIV HGM BioBank, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain

  ⨯